CADTH drug portfolio information sessions


25 September 2015 - The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on CADTH’s Drug Portfolio, including the Common Drug Review (CDR), the pan-Canadian Oncology Drug Review (pCODR), Therapeutic Reviews, and the Rapid Response program. CADTH’s Patient Engagement Strategy, Scientific Advice Program, and the alignment of CDR and pCODR will also be discussed.

The sessions will be presented in English and can be attended in person or by webinar.

For more details, go to:

Michael Wonder

Posted by:

Michael Wonder